Comparison of anesthetic efficacy of 4% articaine and 2% Lidocaine for maxillary Buccal infiltration in patients with irreversible pulpitis. a randomized double- blined clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201204302016N5

Enrollment

Registered

2013-11-23

Start date

2013-11-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irreversible pulpitis.

Interventions

Intervention 1: Buccal infiltration injection of one cartrige(1.8 ml) articaine 4%. Intervention 2: Buccal infiltration injection of one cartrige(1.8 ml) lidocaine 2%.

Treatment - Drugs

Buccal infiltration injection of one cartrige(1.8 ml) articaine 4%

Buccal infiltration injection of one cartrige(1.8 ml) lidocaine 2%

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The exclusion criteria were the presence of systemic disorders; a sensitivity to articaine 4%with 1:100000 epinephrine and lidocaine2% with 1:80,000 epinephrine; the presence of widening of the periodontal ligament space; the presence of a periapical radiolucency; lactation; pregnancy. Inclusion criteria included healthy patients having a first maxillary molar tooth with irreversible pulpitis and normal periapical radiographic appearance, whit out spontaneously pain that to be needed emergency treatment.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain degree. Timepoint: Befor and after intervention. Method of measurement: Visual Analogous Scale(VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamid Rreza Hosseini

Kerman University of Medical Sciences

hamid_h1979@yahoo.com+98 34 1247 7841

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026